+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Bioprocess Containers Market Report and Forecast 2023-2031

  • PDF Icon


  • 160 Pages
  • June 2023
  • Region: Global
  • Expert Market Research
  • ID: 5855113
The bioprocess containers market was valued at USD 3.9 billion in 2022, driven by the increasing acceptance of single-use technologies in biopharmaceutical manufacturing. across the globe. The market size is anticipated to grow at a CAGR of 21% during the forecast period of 2023-2031 to achieve a value of USD 21.3 billion by 2031.

Bioprocess Containers: Introduction

Bioprocess containers, also known as single-use bioprocess containers or disposable bioprocess containers, are specialized containers used in the biopharmaceutical and biotechnology industries for various bioprocessing applications. These containers are designed to handle, store, and transport sensitive biological materials, cell culture media, vaccines, and other biopharmaceutical products throughout different stages of bioproduction. Bioprocess containers are a key component of single-use bioprocessing systems, which have gained popularity in recent years due to their advantages over traditional stainless-steel systems.

Bioprocess containers have become increasingly popular in biopharmaceutical manufacturing and research due to their efficiency, safety, and cost-effectiveness. Their usage is expected to continue growing as the biopharmaceutical industry embraces single-use technologies and seeks to optimize bioprocessing operations.

Key Trends in the Global Bioprocess Containers Market

Some key market trends for bioprocess containers include:

  • Increased Adoption of Single-Use Technologies: The biopharmaceutical industry's growing acceptance of single-use technologies, including bioprocess containers, continues to drive the market's expansion. Single-use systems offer advantages such as reduced cross-contamination risks, faster turnaround times, and lower capital and operational costs, making them increasingly attractive to biopharmaceutical manufacturers
  • Customization and Flexibility: Biopharmaceutical companies are seeking bioprocess containers that can be customized to suit their specific process requirements. Manufacturers are offering a wide range of container sizes, configurations, and integrated components, allowing for greater flexibility and adaptability in bioprocessing operations
  • Growing Biopharmaceutical Production: The global demand for biopharmaceuticals, including monoclonal antibodies, vaccines, and cell-based therapies, is on the rise. Bioprocess containers play a critical role in large-scale biopharmaceutical production, enabling efficient and cost-effective manufacturing processes
  • Advancements in Materials and Technology: Ongoing research and development efforts are focused on improving the materials used in bioprocess containers, ensuring biocompatibility, and enhancing container performance. Advancements in bag film materials, aseptic connectors, and integrated systems contribute to the market's growth
  • Expansion in Emerging Economies: The market for bioprocess containers is witnessing growth in emerging economies, such as those in Asia-Pacific and Latin America. The increasing adoption of biopharmaceutical manufacturing in these regions, coupled with rising investments in healthcare infrastructure, is contributing to market expansion

Global Bioprocess Containers Market Segmentations

The market can be categorised into containers, applications, end user, and region.

Market Breakup by Type of Containers

  • 2D Bioprocess Containers
  • 3D Bioprocess Containers
  • Other Containers and Accessories

Market Breakup by Applications

  • Upstream Process
  • Downstream Process
  • Process Development
  • Others
  • Hospitals/Clinic

Market Breakup by End User

  • Biopharmaceutical Companies
  • Life Science R&D Companies
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Bioprocess Containers Market Overview

The bioprocess containers market is driven by several key factors that contribute to its growth and widespread adoption in the biopharmaceutical and biotechnology industries. One of the primary drivers is the increasing acceptance of single-use technologies in biopharmaceutical manufacturing. Bioprocess containers offer numerous advantages, including reduced risk of cross-contamination, faster turnaround times, and lower capital and operational costs compared to traditional stainless-steel systems. The rising demand for biopharmaceutical products, such as monoclonal antibodies, vaccines, and cell-based therapies, is also propelling the market's expansion. Bioprocess containers play a crucial role in large-scale biopharmaceutical production, enabling efficient and cost-effective manufacturing processes.

Moreover, advancements in materials and technology are contributing to the market's growth, with ongoing research focused on improving biocompatibility, performance, and sustainability of bioprocess containers. Regulatory support and clear guidelines for the use of single-use bioprocessing technologies further facilitate their adoption in the industry.

Key Players in the Global Bioprocess Containers Market

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Thermo Fisher Scientific Inc
  • Cytiva Europe GmbH
  • Saint-Gobain Group
  • Lonza Group AG
  • Avantor Funding Inc
  • Merck KGaA
  • Sartorius AG
  • CellBios Healthcare and Lifesciences Pvt Ltd
  • Cole-Parmer Instrument Co
  • Biomass Ventures Pte Ltd
The publisher always strives to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Bioprocess Containers Market Overview
3.1 Global Bioprocess Containers Market Historical Value (2016-2022)
3.2 Global Bioprocess Containers Market Forecast Value (2023-2031)
4 Global Bioprocess Containers Market Dynamics
4.1 Market Drivers and Constraints
4.2 SWOT Analysis
4.3 Porter’s Five Forces Model
4.4 Key Demand Indicators
4.5 Key Price Indicators
4.6 Industry Events, Initiatives, and Trends
4.7 Value Chain Analysis
5 Global Bioprocess Containers Market Segmentation
5.1 Global Bioprocess Containers Market by Type of Containers
5.1.1 Market Overview
5.1.2 2D Bioprocess Containers
5.1.3 3D Bioprocess Containers
5.1.4 Other Containers and Accessories
5.2 Global Bioprocess Containers Market by Applications
5.2.1 Market Overview
5.2.2 Upstream Process
5.2.3 Downstream Process
5.2.4 Process Development
5.2.5 Others
5.2.6 Hospitals/Clinic
5.3 Global Bioprocess Containers Market by End User
5.3.1 Market Overview
5.3.2 Biopharmaceutical Companies
5.3.3 Life Science R&D Companies
5.3.4 Others
5.4 Global Bioprocess Containers Market by Region
5.4.1 Market Overview
5.4.2 North America
5.4.3 Europe
5.4.4 Asia Pacific
5.4.5 Latin America
5.4.6 Middle East and Africa
6 North America Bioprocess Containers Market
6.1 Market Share by Country
6.2 United States of America
6.3 Canada
7 Europe Bioprocess Containers Market
7.1 Market Share by Country
7.2 United Kingdom
7.3 Germany
7.4 France
7.5 Italy
7.6 Others
8 Asia Pacific Bioprocess Containers Market
8.1 Market Share by Country
8.2 China
8.3 Japan
8.4 India
8.6 Australia
8.7 Others
9 Latin America Bioprocess Containers Market
9.1 Market Share by Country
9.2 Brazil
9.3 Argentina
9.4 Mexico
9.5 Others
10 Middle East and Africa Bioprocess Containers Market
10.1 Market Share by Country
10.2 Saudi Arabia
10.3 United Arab Emirates
10.4 Nigeria
10.5 South Africa
10.6 Others
11 Patent Analysis
11.1 Analysis by Type of Patent
11.2 Analysis by Publication year
11.3 Analysis by Issuing Authority
11.4 Analysis by Patent Age
11.5 Analysis by CPC Analysis
11.6 Analysis by Patent Valuation
11.7 Analysis by Key Players
12 Grants Analysis
12.1 Analysis by year
12.2 Analysis by Amount Awarded
12.3 Analysis by Issuing Authority
12.4 Analysis by Grant Application
12.5 Analysis by Funding Institute
12.6 Analysis by NIH Departments
12.7 Analysis by Recipient Organization
13 Funding Analysis
13.1 Analysis by Funding Instances
13.2 Analysis by Type of Funding
13.3 Analysis by Funding Amount
13.4 Analysis by Leading Players
13.5 Analysis by Leading Investors
13.6 Analysis by Geography
14 Partnership and Collaborations Analysis
14.1 Analysis by Partnership Instances
14.2 Analysis by Type of Partnership
14.3 Analysis by Leading Players
14.4 Analysis by Geography
15 Regulatory Framework
15.1 Regulatory Overview
15.1.1 US FDA
15.1.2 EU EMA
15.1.5 Others
16 Supplier Landscape
16.1 Thermo Fisher Scientific Inc.
16.1.1 Financial Analysis
16.1.2 Product Portfolio
16.1.3 Demographic Reach and Achievements
16.1.4 Mergers and Acquisition
16.1.5 Certifications
16.2 Cytiva Europe GmbH.
16.2.1 Financial Analysis
16.2.2 Product Portfolio
16.2.3 Demographic Reach and Achievements
16.2.4 Mergers and Acquisition
16.2.5 Certifications
16.3 Saint-Gobain Group.
16.3.1 Financial Analysis
16.3.2 Product Portfolio
16.3.3 Demographic Reach and Achievements
16.3.4 Mergers and Acquisition
16.3.5 Certifications
16.4 Lonza Group AG.
16.4.1 Financial Analysis
16.4.2 Product Portfolio
16.4.3 Demographic Reach and Achievements
16.4.4 Mergers and Acquisition
16.4.5 Certifications
16.5 Avantor Funding Inc.
16.5.1 Financial Analysis
16.5.2 Product Portfolio
16.5.3 Demographic Reach and Achievements
16.5.4 Mergers and Acquisition
16.5.5 Certifications
16.6 Merck KGaA.
16.6.1 Financial Analysis
16.6.2 Product Portfolio
16.6.3 Demographic Reach and Achievements
16.6.4 Mergers and Acquisition
16.6.5 Certifications
16.7 Sartorius AG.
16.7.1 Financial Analysis
16.7.2 Product Portfolio
16.7.3 Demographic Reach and Achievements
16.7.4 Mergers and Acquisition
16.7.5 Certifications
16.8 CellBios Healthcare and Lifesciences Pvt Ltd.
16.8.1 Financial Analysis
16.8.2 Product Portfolio
16.8.3 Demographic Reach and Achievements
16.8.4 Mergers and Acquisition
16.8.5 Certifications
16.9 Cole-Parmer Instrument Co.
16.9.1 Financial Analysis
16.9.2 Product Portfolio
16.9.3 Demographic Reach and Achievements
16.9.4 Mergers and Acquisition
16.9.5 Certifications
16.10 Biomass Ventures Pte Ltd.
16.10.1 Financial Analysis
16.10.2 Product Portfolio
16.10.3 Demographic Reach and Achievements
16.10.4 Mergers and Acquisition
16.10.5 Certifications
17 Global Bioprocess Containers Market - Distribution Model (Additional Insight)
17.1 Overview
17.2 Potential Distributors
17.3 Key Parameters for Distribution Partner Assessment
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket
  • *Additional insights provided are customisable as per client requirements.

Companies Mentioned

  • Thermo Fisher Scientific Inc.
  • Cytiva Europe GmbH.
  • Saint-Gobain Group.
  • Lonza Group AG.
  • Avantor Funding Inc.
  • Merck KGaA.
  • Sartorius AG.
  • CellBios Healthcare and Lifesciences Pvt Ltd.
  • Cole-Parmer Instrument Co.
  • Biomass Ventures Pte Ltd.



Table Information